The focus of the DG is on the technical assessments that should be included in any regulatory submission for a device made of Nitinol.
William A. Hyman, Professor Emeritus of Biomedical Engineering, Texas A&M University, & Adjunct Professor of Biomedical Engineering, The Cooper Union04.30.19
The successful acquisition of AIM represents a major step forward in Graham's investment thesis to build a premier medical device manufacturing business.
Turning to emerging markets for long-term growth can be a savvy business strategy�as long as companies can overcome the challenges associated with setting up shop in these areas.
A host of factors�from market forces to new cutting-edge development processes�are shaping the next generation of orthopedic instruments, cases and trays.